retatrutide nerve pain Retatrutide: The Triple-Hormone Weight Loss Drug Retatrutide Dysesthesia: What's Happening Under

Type 2 diabetes trial results were published in The Lancet in 2023, showing meaningful improvements in blood sugar control alongside substantial weight loss

Currently, the efficacy estimand for injectable semaglutide demonstrates greater weight loss compared to the available oral tablet

Some research suggests these medications may reduce inflammation and improve insulin signaling in the brain, which are mechanisms believed to play a role in neurodegenerative diseases

14 The successful translation of GLP-1 RAs from injectables to an effective oral formulation challenges the longheld assumption that peptides and proteins cannot be reliably delivered via the gastrointestinal (GI) tract, redefining what is possible for biologic drug delivery